Maithé TAUBER, MD

Trials

Studies that name Maithé TAUBER, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:35 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT05032326 · Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial

  University Hospital, Toulouse · unknown · Prader-Willi Syndrome · principal investigator
• N/A
  NCT04768803 · Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity

  University Hospital, Toulouse · unknown · Angelman Syndrome, Smith-Magenis Syndrome, X Fragile Syndrome · principal investigator
• N/A
  NCT04526379 · Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation

  University Hospital, Toulouse · completed · Prader-Willi Syndrome · principal investigator
• Ph3
  NCT04283578 · Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome

  University Hospital, Toulouse · completed · Prader-Willi Syndrome · principal investigator
• Ph2/Ph3
  NCT02804373 · Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome

  University Hospital, Toulouse · completed · Prader-Willi Syndrome · principal investigator
• Ph4
  NCT01298180 · Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?

  University Hospital, Toulouse · completed · Prader-Willi Syndrome, Growth Hormone Deficiency · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.